Vittorio Pedicini
- Surgery top 5%
- Hepatology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Epidemiology
- Co-authors
- Dario PorettiArmando SantoroGuido TorzilliCarlo CarnaghiLorenza RimassaEzio LanzaGiovanni MauriLuigi Solbiati
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (24 papers)Gallbladder and Bile Duct Disorders (10 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ItalyUnited StatesIsrael
In The Last Decade
Vittorio Pedicini
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 83
- Surgery 546
- Hepatology 453
- Pulmonary and Respiratory Medicine 450
- Oncology 314
- Epidemiology 165
Countries citing papers authored by Vittorio Pedicini
This map shows the geographic impact of Vittorio Pedicini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vittorio Pedicini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vittorio Pedicini more than expected).
Fields of papers citing papers by Vittorio Pedicini
This network shows the impact of papers produced by Vittorio Pedicini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vittorio Pedicini. The network helps show where Vittorio Pedicini may publish in the future.
Co-authorship network of co-authors of Vittorio Pedicini
This figure shows the co-authorship network connecting the top 25 collaborators of Vittorio Pedicini. A scholar is included among the top collaborators of Vittorio Pedicini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vittorio Pedicini. Vittorio Pedicini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 28 | |
| 3 | 14 | |
| 4 | 14 | |
| 5 | 8 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 13 | |
| 9 | 5 | |
| 10 | 15 | |
| 11 | 4 | |
| 12 | 32 | |
| 13 | 28 | |
| 14 | 43 | |
| 15 | 17 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 18 | |
| 19 | 32 | |
| 20 | 99 |
About Vittorio Pedicini
Vittorio Pedicini is a scholar working on Hepatology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 65 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Gallbladder and Bile Duct Disorders (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). The work is most often cited by research in Hepatology (453 citations), Internal Medicine (116 citations) and Pulmonary and Respiratory Medicine (450 citations). Vittorio Pedicini has collaborated with scholars based in Italy, United States and Israel. Frequent co-authors include Dario Poretti, Armando Santoro, Guido Torzilli, Carlo Carnaghi, Lorenza Rimassa, Ezio Lanza, Giovanni Mauri, Luigi Solbiati, Nicola Personeni and Plinio Rossi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.